The Anticancer Fund invites letters of intent for its clinical trials grants in brain metastases. These support clinical trial activities in patients diagnosed with brain metastases. The aim is to improve survival rate or induce durable responses.
Applicants may be based anywhere in the world and may apply as international consortia. The leading team must have prior experience of clinical trials on brain metastases.
The grant is worth up to €500,000
Deadline: 1st May 2022